Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Launched by M.D. ANDERSON CANCER CENTER · Sep 22, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on improving the care of patients with prostate cancer by gathering expert opinions on the most important information that should be included in medical reports. Using a method called the Delphi technique, a group of specialized doctors will work together to agree on key data elements that are essential for standardizing how prostate cancer is reported in electronic health records. This aims to help doctors better manage patient care from diagnosis through treatment and survivorship.

To be eligible for this trial, participants must be at least 21 years old, board-certified in fields like Radiation Oncology, Urology, or Medical Oncology, and actively treating patients with prostate cancer. Participants should be able to communicate in English. It's important to note that this study is open to all genders and does not exclude participants based on age, race, or pregnancy status. Those who are not board-certified or do not treat prostate cancer, as well as children and individuals unable to provide consent, will not be included. Participants can expect to contribute to a vital effort that could lead to better cancer care practices worldwide.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 21 and above
• • Board certification in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
• • Maintenance of an active practice that includes prostate cancer patients
• • English speaking
• Exclusion Criteria:
• • Medical providers that are not board certified in the professions and/or those who do not treat prostate cancer
• • Prisoners, children, and adults unable to consent to participation will also be excluded
• • No exclusions were made based on sex, age, racial/ethnic background, or pregnancy status